Soros sharply increased his position in Intel before the crash. Should you buy these shares?

The investment firm Soros Fund Management has significantly increased its stake in Intel / Photo: UVL / Shutterstock.com
Soros Fund Management, the investment firm and family office of billionaire George Soros, increased its stake in chipmaker Intel by 2,700% in the third quarter, according to a disclosure in a Form 13F regulatory filing. Soros’s firm purchased an additional 2.73 million shares for $355 million. The entire stake now accounts for 5.25% of its portfolio. This is its largest position, second in size only to put options on the XLE and XOP energy exchange-traded funds.
Intel's stock plummeted 29% on October 30, marking one of the worst days in the company's history. The day before, the chipmaker warned in its quarterly report of a significant cash outflow due to slowing PC sales, manufacturing challenges, and substantial costs associated with expanding its product line. Due to the sharp drop in the stock price, a group of Intel shareholders filed a class-action lawsuit against the company, accusing management of concealing the real problems, according to Reuters.
Investment firms file Form 13F 45 days after the end of the quarter. Since this data is current as of September 30, it is not known for certain whether Soros’s fund took any action regarding Intel shares in the run-up to and during the sell-off.
What to Do with Stocks
Caution prevails on Wall Street regarding Intel. On October 30, the day the stock plummeted, Bank of America analyst Vivek Arya downgraded the stock to a neutral “Hold” rating, withdrawing his “Buy” recommendation. At the same time, BofA lowered its price target from $145 to $100. On November 12, it lowered the target once again—this time to $80—citing Intel’s uncertain business outlook. This implies a 35% increase from the closing price on November 13.
Over the past couple of weeks, other investment firms—including UBS, Citigroup, Wedbush, and TD Cowen—have also lowered their price targets for Intel shares. All of them maintained their neutral ratings. JPMorgan reaffirmed its “sell” recommendation on the chipmaker’s stock and also revised its price target to $80.
The average target price for the stock is now $91, which is 54% higher than the last closing price. The overwhelming majority recommend holding the position without making any changes—31 out of 51 analysts gave this advice. Nineteen recommend buying, and only one recommends selling.
Since the beginning of the year, Intel's stock has risen by nearly 62% as the company benefits from growing demand for central processing units for AI data centers. In premarket trading on November 16, the stock fell by more than 4%.
This article was AI-translated and verified by a human editor



